• Neonatal MSG administration induced anxiogenic-like behavior in adult rats.
Introduction
Monosodium glutamate (MSG), the sodium salt of glutamic acid, is widely used as a flavor enhancer in human diets [1] , making its toxicity a significant area of animal and human research.
The administration of MSG in animals during the neonatal period, when the blood brain barrier is not fully developed, leads to destruction of neuronal cell bodies located in the central nervous system (CNS), producing damage in various brain regions [2, 3] . Consequently, upon reaching adulthood these animals exhibit behavioral deficits [4, 5] and neurochemical disturbances [6, 7] .
The neuronal networks in the vertebrate brain consist of excitatory principal neurons (glutamatergic) and inhibitory interneurons (GABAergic), which interact to establish a functional balance avoiding the appearance of disease [8] . The GABAergic system may be considered an important target for MSG excitotoxicity, once those GABAergic Physiology & Behavior 155 (2016) [1] [2] [3] [4] [5] [6] [7] [8] neurons express glutamate receptors and coexist with glutamatergic neurons [9, 10] . Moreover, it has been demonstrated that neonatal administration of MSG alters [ 3 H]GABA release and total glutamic acid decarboxylase (GAD) activity [11] in different brain regions.
It is known that GABAergic dysfunction is strongly implicated in anxiety [12, 13] , a serious disorder with symptoms manifesting at the psychological, behavioral and physiological levels. In this context, previous data demonstrated that neonatal administration of MSG induces depressive-like and anxiogenic-like behaviors in young rats which were related to the increase in the 5-hydroxytryptamin serotonin (5-HT) uptake in cerebral cortices [6] and increased sensitivity of serotoninergic neurons [14] .
In addition to changes in neurotransmitter systems, brain-derived neurotrophic factor (BDNF), a secretory protein of neurotrophin family, has been implicated in the pathophysiology of anxiety disorders [15, 16] and has been explored as a potential target for the development of anxiolytic drugs [17] . The effects of BDNF may be mediated through the binding of the tyrosine protein kinase B (TrKB) receptor, which leads to activation of intracellular signaling, including the phosphatidyl inositol 3-kinase (PI-3K)-Akt phosphorylation [18] , an important protein that promotes cell survival [19] .
In this way, substances effective in modulating different systems and signaling pathways are of significant interest as a potential treatment for anxiety disorders. Over the past decade some organoselenium compounds have been studied by our research group in view of their pharmacological properties [20] , such as neuroprotective [21] , antioxidant [22] , anti-inflammatory, antinociceptive [23] and antidepressant-like [24] . Among them, diphenyl diselenide has been reported as a potential antidepressant-and anxiolytic-like agent [25, 26] and these effects are related to the modulation of GABA A and 5-HT receptors [27] .
Considering the above mentioned, the aim of this study was to investigate the effect of diphenyl diselenide in the anxiety-like behavior induced by MSG in rats as well as to demonstrate the involvement of 5-HT and GABA uptake and the BDNF-Akt pathway in this effect.
Materials and methods
The experiments were carried out using male and female newborn Wistar rats (pups weighing around 5 g) from our own breeding colony. Pups were obtained from four different litters. Both male and female rats were used based on our previous study [6] . The animals were kept on a 12 h light/dark cycle with lights turned on every day at 7:00 a.m., at room temperature (22 ± 1°C) with free access to water and food. All behavioral tests were carried out between 08:00 a.m. and 04:00 p.m. The present experimental study was approved by the Institutional Ethics Committee on Care and Use of Experimental Animal Resources from the Federal University of Santa Maria-RS -Brazil and registered under the number 028/2014. All efforts were made to minimize animal suffering and to reduce the number of animals used in the experiments.
Drugs
Diphenyl diselenide (PhSe) 2 was prepared in our laboratory according to a previous method described [28] . 1 H and 13 
C Nuclear Magnetic
Resonance Spectroscopy analysis showed analytical and spectroscopic agreement with the assigned structures. The chemical purity of these organoselenium compounds (99.9%) was determined by gas chromatography-mass spectrometry (Shimadzu QP2010PLUS GC/MS combination). (PhSe) 2 was dissolved in canola oil.
Monosodium glutamate (MSG) was purchased from Sigma-Aldrich (St. Louis, MO, USA). All other chemicals were of analytical grade and obtained from standard commercial suppliers.
Experimental design
Group-1 pups (n = 14 animals/group) received saline 1-10th day and were kept undisturbed until 59th day. On 60th day, this group was divided into two namely, control (received canola oil) and (PhSe) 2 (received test drug 1 mg/kg) for 7 consecutive days [5] (n = 7 animals/group).
Group-2 pups (n = 14 animals/group) received MSG (4 g/kg body weight) once a day 1-10th day and were kept undisturbed until 59th day. On 60th day, this group was divided into two namely, MSG (received canola oil) and (PhSe) 2 (received test drug 1 mg/kg) for seven consecutive days [5] (n = 7 animals/group). Regarding the dose of (PhSe) 2 used in this study, repeated treatment with 1 mg/kg of (PhSe) 2 was chosen on the basis of the fact that this is an ineffective dose of this compound when administered as a single dose in rat models of anxiety [25] .
Thirty minutes after the last (PhSe) 2 administration, the animals were submitted to spontaneous locomotor activity monitor, the elevated plus maze (EPM) test and the contextual fear conditioning test. Other cohorts of rats were killed by decapitation without anesthesia in order to extract the cerebral cortices and hippocampi, which were used for ex vivo assays (Fig. 1). 2.2.1. Behavioral tests 2.2.1.1. Spontaneous locomotor activity. The rat spontaneous locomotor activity was performed in order to discard non-specific effects of treatments. The locomotor activity monitor (LAM) is a clear acrylic plastic box (45 × 45 × 45 cm) with a removable plastic lid perforated with holes for ventilation. The LAM (Model EP149, Insight Instruments Ltda, Sao Paulo, BR) contains photocell beams and detectors that are mounted on opposite walls (2 cm above the chamber floor). General locomotor activity and the rat position in the chamber are detected by breaks of the photocell beams (frontal and lateral sensors), which are recorded using a video tracking software (Software activity monitor Insight). Animals (n = 7 animals/group) were placed in the center of the apparatus and allowed to freely explore the arena. Total distance traveled (mm), velocity (mm/s) and time in the central square (s) were recorded for a 4 min period. [29] . The elevated plus maze apparatus consists of arms (length: 50 cm, width: 10 cm, height from floor: 50 cm) in a cross-shaped form and a central region (10 cm 2 ). Two of the arms were enclosed on three sides by walls (height: 50 cm), whereas the other two were not. The enclosed or open arms of the maze faced each other. The maze is lit by a dim light placed above the central platform. Each rat was placed at the center of the maze facing one of the open arms and the number of entries, the time spent in the open arms and the number of dives were recorded manually (using a stop watch) by an experimenter during a 5 min test period. An entry was defined as placing all four paws within the boundaries of the arm. The anxiolytic effectiveness of a drug is illustrated by a significant statistical augmentation of parameters in open arms (time and/or entries) [30] (n = 7 animals/group).
Contextual fear conditioning test.
The contextual fear conditioning test was performed as described by [31] with modifications. During the contextual training phase, each rat received ten footshocks (2.0 mA) with intervals of 20 s between the footshocks. Twenty-four hours after training, rats were individually placed into the training chamber and the time that animals spent exhibiting freezing was measured by an experimenter using a stop watch during 5 min. Freezing was considered as a body immobility and the absence of vibrissae movement associated with sniffing [32] . At the end of the test session, the animals were removed from the chamber and returned to their home cages (n = 7 animals/group). Cerebral cortices and hippocampus were dissected, and the slices (0.4 mm) were obtained using a Mc Illwain tissue chopper. Slices were transferred to multiwell dishes and washed with 300 μl HBSS. After 10 min of pre-incubation, the uptake assay was performed by adding 16.6 nM (hippocampus) and 8.3 nM (cerebral cortices) [ 3 H]GABA in 300 μl HBSS at 37°C. Incubation was terminated after 5 min (hippocampus) or 7 min (cerebral cortices) by three ice-cold washes with 1 ml HBSS immediately followed by the addition of 0.5 M NaOH, which was kept overnight. An aliquot of 10 μl was removed to protein determination. Nonspecific uptake was measured using the same protocol described above, with differences in the temperature (4°C ) and medium composition (choline chloride instead of sodium chloride). Na + -dependent uptake was considered as the difference between the total uptake and the nonspecific uptake. Both uptakes were performed in triplicate. Incorporated radioactivity was measured using a liquid scintillation counter (Wallac 1409). Results were expressed as pmol of [ 3 H]GABA uptake/mg protein/min (n = 4 animals/group).
[
3 H] 5-HT uptake 2.2.2.2.1. Preparation of synaptosomes. The synaptosomes were obtained as described by Gray and Whittaker [34] with some modifications. The cerebral cortices and hippocampi were placed into ice-cold sucrose solution (0.32 M, pH 7.4), cut into small pieces and homogenized using a glass Potter-Elvehjem tube with a Teflon pestle (10 up and down strokes). The homogenate solution was centrifuged at 1000 ×g at 4°C for 10 min in a refrigerated centrifuge. The pellet was discarded and the supernatant was subsequently centrifuged at 12,000 ×g at 4°C for 20 min. The final pellet of this centrifugation was suspended in ten volumes of ice-cold sucrose solution (0.32 M, pH 7.4) and then used as a crude synaptosome preparation in the [ ] 5-HT uptake into synaptosomes was carried out as described by Yura, Kiuchi [35] with some modifications. The synaptosomal suspension (125 μg of protein) was pre-incubated at 37°C for 10 min in a physiological salt solution (pH 7.4, adjusted with phosphoric acid 1%) of the following composition: 108 mM NaCl, 1 mM KCl, 27 mM NaHCO 3 , 1.1 mM NaH 2 PO 4 , 0.1 mM pargyline, 
Protein determination.
The protein concentration was determined according to Bradford [36] using bovine serum albumin (1 mg/ ml) as a standard.
Statistical analysis
The normality of data was analyzed using a D'Agostino and Pearson omnibus K2 normality test. Data were analyzed by Two-way ANOVA (MSG × (PhSe) 2 ) of variance followed by the post-hoc analysis Duncan's test, when appropriate. Main effects are presented only when the first order interaction was non-significant. Descriptive statistics data were expressed as the mean (s) ± S.E.M. Pearson's correlation coefficient was used for the estimation of correlation between BDNF levels and AKT-phosphorylation levels. For the correlation analysis, only data from animals of MSG and MSG + (PhSe) 2 groups were used. All analyses were performed using the STATISTICA for Windows software when compared to the MSG group (two-way ANOVA followed by the Duncan's test). Version 7 (StatSoft, Oklahoma, USA). Probability values less than 0.05 (p b 0.05) were considered as statistically significant.
Results

Behavioral tests
Spontaneous locomotor activity
There was no significant difference among groups in total distance traveled and velocity (Table 1) .
In addition, two-way ANOVA of central square time revealed a significant MSG × (PhSe) 2 interaction (F 1,23 = 5.4844, p b 0.05). Post-hoc analyses indicated that the administration of MSG to rats decreased the central quadrant time when compared with that of the control group and (PhSe) 2 treatment reversed this decreased induced by MSG (Fig.2) . (Fig. 3A, B, C and D) .
The effects of (PhSe) 2 on parameters denoting anxiolytic-like activity were independent from those reflecting locomotor activity [5] .
Contextual fear conditioning test.
During the training phase of the contextual fear conditioning all groups showed the same freezing time. The two-way ANOVA of freezing time revealed a significant MSG × (PhSe) 2 interaction (F 1,24 = 6.5068, p b 0.05). Post-hoc analyses indicated that the time of freezing was increased in the MSG group when compared to that of the control group and that (PhSe) 2 treatment was effective against this increase (Fig.4) fig. 5A , the two-way ANOVA of hippocampal GABA uptake revealed significant main effects of MSG (F 1,12 = 11.3422, p b 0.01) and (PhSe) 2 (F 1,12 = 5.6697, p b 0.05). Post hoc comparisons demonstrated an increase in hippocampal GABA uptake induced by MSG administration when compared with that of the control group and (PhSe) 2 was effective against this increase. No statically significant differences were found among the experimental groups in the cortical GABA uptake (Fig. 5B ). effective in reversing this effect (Fig. 6A) . By contrast, the 5-HT uptake was not altered in cerebral cortices of animals of any experimental groups (Fig. 6B) .
[
Western blot analysis
Two-way ANOVA of hippocampal levels of BDNF (F 1,10 = 6.3492, p b 0.05), p-Akt (F 1,10 = 11.1392, p b 0.01) and Akt phosphorylation (p-Akt/ Aktt/tubulin) (F 1,10 = 25.5133 p b 0.001) showed a significant MSG × (PhSe) 2 interaction. Post hoc comparisons demonstrated that the levels of BDNF (Fig. 7A) , p-Akt (Fig. 8 B) and Akt phosphorylation (Fig. 8C) decreased in hippocampi of rats treated with MSG when compared with those of the control group and that (PhSe) 2 was effective in increasing the levels of these proteins. Both MSG and (PhSe) 2 did not alter the levels of total Akt in hippocampi of rats (Fig. 8A). Figs. 7B and 8D show the representative bands of BDNF and total Akt, p-Akt and β-tubulin, respectively. The Pearson's correlation analysis revealed a positive correlation between BDNF and p-Akt/Akt/tubulin levels (r = 0.8128, p b 0.05).
Discussion
In the present study, (PhSe) 2 elicited an anxiolytic-like behavioral in a model of MSG-induced anxiety in rats. The results provided evidence that hippocampal GABA and 5-HT uptake and the BDNF-Akt pathway are implicated in the anxiolytic-like effect of (PhSe) 2 in rats.
In this study, the administration of MSG in neonatal rats caused central effects, possibly by crossing the blood brain barrier, which led to an anxiogenic-like behavioral in adult rats. The anxiogenic-like behavioral was demonstrated by the increase in anxiogenic parameters in the elevated plus maze test, a decrease of central square time in the LAM and an increase in the time of freezing in the contextual fear conditioning test. In addition, repeated treatment with (PhSe) 2 reversed these effects, demonstrating an anxiolytic-like action of compound.
The disturbances in GABA-glutamate balance have long been involved in anxiety disorders [37] . Accordingly, the current study demonstrated that the administration of MSG increased hippocampal GABA uptake, without changing cortical GABA uptake, which suggests a decrease of hippocampal GABAergic transmission. These results are in accordance with previous studies that suggest a downregulation of GABAergic system by MSG, through a decrease in the GABA release [38] and in the number of GABA-positive cells [3] , besides an increase in the GAD activity, which is related to a possible compensatory mechanism in the surviving GABAergic neurons in hippocampus of 60-dayold rats [11] . Although it has been shown alterations of GABAergic markers in cortices of rats injected with MSG, many of the effects induced by MSG in the hippocampus are contrary to those observed in the cerebral cortices [11, 38] and would explain the observed differences in the GABA uptake among these two structures. Furthermore, UrenaGuerrero, Orozco-Suarez [3] demonstrated a decrease of hippocampal GABA uptake in rats treated with MSG. However, it is important to note that the contradictory results between the previous study and ours could be due to differences in the experimental protocol, such as the time of exposure to MSG and regimen of treatment (continuous or intermittent).
In the present study, MSG induced an increase of 5-HT uptake in hippocampus, suggesting a decrease of cerebral serotonergic neurotransmission in this structure. This result is in agreement with an early study that showed dysfunctions of the serotonergic system in neurons of area postrema induced by administration of MSG to neonatal rats [14] . By contrast, our previous study demonstrated an increase of 5-HT uptake in cerebral cortices of rats treated with MSG [6] , whilst no significant changes in 5-HT uptake were found in this cerebral structure in the present study. These divergent results could be explained by differences in the protocol regimen of MSG treatment, which was five days in a previous study [6] and ten days in the present one.
The 5-HT system plays a role in anxiety, an increased availability of 5-HT or a higher postsynaptic 5-HT receptor activity is responsible for anxiolytic effects, while a decrease in efficiency of 5-HT induces anxiety [39] . Then, one hypothesis to explain the anxiolytic-like action induced by (PhSe) 2 could be the inhibition of the 5-HT uptake in hippocampus.
The effect of (PhSe) 2 in modulating 5-HT and GABA uptake observed in this study is in agreement with a previous study that demonstrated that anxiolytic-like action of (PhSe) 2 involves its interaction with GABA-A and 5-HT receptors [27] . In this sense, it is well known that the inhibition of GABA uptake is used in the treatment of some psychiatric disorders, including anxiety [40] . Studies indicate that acute or chronic administration of tiagabine, a GABA reuptake inhibitor, decreases anxiety-related behavior in rodents [41] . Moreover, selective 5-HT reuptake inhibitors (SSRIs) have been also effective as anxiolytic drugs for long-term therapy [42] . In this context, the results of this study further expand the knowledge about the mechanisms by which (PhSe) 2 modulates GABAergic and serotonergic systems to exert anxiolytic-like effect.
The exposure to high concentrations of MSG early in life induces cell death and changes in the cytoarchitecture of the surviving pyramidal neurons of the hippocampal CA1 [43] , confirming that hippocampus is of the target structures of MSG early in life. Accordingly, all neurochemical alterations induced by MSG in the present study were found in the hippocampus. Previous studies revealed a bidirectional relationship between GABA and 5-HT systems [44] , once these systems are closely interlinked, neuroanatomically and functionally [45] . Considering the relationship between GABA and 5-HT systems, the anxiety-like behavior induced by MSG demonstrated in this study could be, at least in part, related to the increase in the hippocampal GABA and 5-HT uptake.
Although clinical studies have revealed that the dysregulation of serotonergic and GABAergic systems is important in the pathogenesis of anxiety disorders, among several hypotheses [46, 47] evidence have identified modifications of intracellular signaling proteins and target genes that could also contribute to the pharmacological action of antidepressant and anxiolytic therapy [48, 49] . In this sense, a reduction of BDNF signaling has been implicated in the pathophysiology of both bipolar and anxiety disorders [15, 50] as well as early life traumas can induce downregulation of BDNF mRNA and protein levels in the CA1 subregion of hippocampus [51] , a target region of MSG in the neonatal period. Therefore, an important result revealed in the present study was the decrease of hippocampal BDNF levels induced by early life exposure to MSG, which suggests that a modulation of BDNF levels can be involved in anxiety-like behavior induced by MSG early in life.
It has been also reported that the TrkB activation by BDNF stimulates the Akt phosphorylation [18] . Given that MSG induced a decrease in pAkt and Akt phosphorylation levels, it is possible that the low levels of BDNF bound to the TrkB receptor, would lead to a low activation of Akt when MSG is administered to rats. Corroborating this, a positive Pearson's correlation was found between the levels of BDNF and Akt phosphorylation. Furthermore, Akt has been proposed to be a convergence point for diverse survival signals [52] . Therefore, the decrease in Akt phosphorylation levels could be related to death of neuronal cell induced by MSG [43] . In addition, (PhSe) 2 treatment was effective in reversing the increase in the levels of BDNF, p-Akt and Akt phosphorylation induced by MSG, indicating that this signaling pathway can be the new target for the anxiolytic-like effect of (PhSe) 2. We assume as potential limitation of this study the use of both male and female rats, which might be a possible confounding factor in this study [53, 54] .
Conclusion
Considering what was mentioned above, our findings illustrate the potential anxiolytic-like of (PhSe) 2 in adult rats exposed to MSG during their neonatal period and suggest that this effect is likely to be mediated by the modulation of hippocampal GABA and 5-HT uptake as well as the BDNF-Akt pathway.
